MX336067B - Celula madre para uso terapeutico, la cual se deriva de monocito humano y metodo para inducir la misma. - Google Patents
Celula madre para uso terapeutico, la cual se deriva de monocito humano y metodo para inducir la misma.Info
- Publication number
- MX336067B MX336067B MX2011005480A MX2011005480A MX336067B MX 336067 B MX336067 B MX 336067B MX 2011005480 A MX2011005480 A MX 2011005480A MX 2011005480 A MX2011005480 A MX 2011005480A MX 336067 B MX336067 B MX 336067B
- Authority
- MX
- Mexico
- Prior art keywords
- stem cell
- monocyte
- inducing
- derived
- therapeutic use
- Prior art date
Links
- 210000001616 monocyte Anatomy 0.000 title abstract 4
- 230000001939 inductive effect Effects 0.000 title abstract 3
- 210000000130 stem cell Anatomy 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 2
- 230000032459 dedifferentiation Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940124597 therapeutic agent Drugs 0.000 abstract 2
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 abstract 1
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 abstract 1
- 238000002659 cell therapy Methods 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000002270 gangliosides Chemical class 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000419 plant extract Substances 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
Abstract
La presente invención se refiere a células madre obtenidas cultivando monocitos en presencia de (i) M-CSF y (ii) por lo menos un miembro seleccionado del grupo que consiste de un gangliósido y un extracto soluble en agua derivado de plantas, desdiferenciando de esta manera los monocitos; un agente terapéutico para tratar células, tejidos u órganos dañados; un agente de fármaco para células; un método para producir células madre; un medio de cultivo para desdiferenciar monocitos; un agente inductor de desdiferenciación; un kit de fármaco para células; un kit para producir células desdiferenciadas; y una composición farmacéutica.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008299359 | 2008-11-25 | ||
PCT/JP2009/069648 WO2010061781A1 (ja) | 2008-11-25 | 2009-11-19 | ヒト単球由来治療用幹細胞およびその誘導方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2011005480A MX2011005480A (es) | 2011-06-20 |
MX336067B true MX336067B (es) | 2016-01-06 |
Family
ID=42225657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011005480A MX336067B (es) | 2008-11-25 | 2009-11-19 | Celula madre para uso terapeutico, la cual se deriva de monocito humano y metodo para inducir la misma. |
Country Status (17)
Country | Link |
---|---|
US (2) | US9169463B2 (es) |
EP (1) | EP2365061A4 (es) |
JP (1) | JP5800505B2 (es) |
KR (1) | KR101682731B1 (es) |
CN (1) | CN102245757B (es) |
AR (1) | AR074406A1 (es) |
AU (1) | AU2009320881B2 (es) |
BR (1) | BRPI0921371A2 (es) |
CA (3) | CA2744289A1 (es) |
CO (1) | CO6341484A2 (es) |
IL (1) | IL212638A (es) |
MX (1) | MX336067B (es) |
RU (1) | RU2573906C2 (es) |
TW (1) | TWI539000B (es) |
UA (1) | UA110691C2 (es) |
WO (1) | WO2010061781A1 (es) |
ZA (1) | ZA201103268B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102399741A (zh) * | 2010-09-19 | 2012-04-04 | 林雄斌 | 逆向分化体细胞产生造血干细胞的培养液、方法及用途 |
CN109952107A (zh) * | 2016-09-14 | 2019-06-28 | Tes控股股份有限公司 | Lin28a激活剂及其使用 |
CN107904202B (zh) * | 2017-11-22 | 2018-11-20 | 北京恩诺生物科技有限公司 | 一种制备多能干细胞样细胞的方法、组合物和应用 |
JP6375076B1 (ja) * | 2018-02-19 | 2018-08-15 | 株式会社 バイオミメティクスシンパシーズ | 間葉系幹細胞を用いたアトピー性皮膚炎治療における治療効果予測判定法 |
JP6574292B2 (ja) * | 2018-07-21 | 2019-09-11 | 株式会社 バイオミメティクスシンパシーズ | 間葉系幹細胞を用いたアトピー性皮膚炎治療における治療効果予測判定法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4778787A (en) * | 1985-12-20 | 1988-10-18 | Trustees Of Boston University | Method for treatment of angina and myocardial infarctions with omental lipids |
US5272138A (en) * | 1988-02-12 | 1993-12-21 | The Biomembrane Institute | Naturally occurring gangliosides containing de-N-acetyl-sialic acid and their applications as modifiers of cell physiology |
US6084060A (en) * | 1996-12-09 | 2000-07-04 | Imclone Systems Incorporated | Composition and method for preserving progenitor cells |
DE19651443A1 (de) * | 1996-12-11 | 1998-06-18 | Hoechst Ag | Selbstverstärkende, pharmakologisch kontrollierbare Expressionssysteme |
EP0893493A3 (de) * | 1997-07-21 | 2002-12-04 | Aventis Pharma Deutschland GmbH | Genetisch veränderte Zellen und deren Verwendung in der Prophylaxe oder Therapie von Erkrankungen |
US20030157113A1 (en) * | 1999-12-28 | 2003-08-21 | Terman David S. | Compositions and methods for treatment of neoplastic disease |
TWI288779B (en) * | 2002-03-28 | 2007-10-21 | Blasticon Biotech Forschung | Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
DE10214095C1 (de) * | 2002-03-28 | 2003-09-25 | Bernd Karl Friedrich Kremer | Dedifferenzierte, programmierbare Stammzellen monozytären Ursprungs, sowie deren Herstellung und Verwendung |
JP2006521405A (ja) | 2003-03-27 | 2006-09-21 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 発作回復におけるエリトロポイエチンの使用 |
BRPI0417186A (pt) * | 2003-12-02 | 2007-03-06 | Celgene Corp | método de tratamento de um indivìduo tendo uma hemoglobinopatia ou uma anemia, de modulação da diferenciação de uma célula-tronco ou precursora de cd34+ para uma linhagem de eritróides, e, composição farmacêutica |
US20050260748A1 (en) * | 2004-02-27 | 2005-11-24 | Michigan State University | Adult stem cells and uses thereof |
AU2007339767B2 (en) | 2006-12-29 | 2013-09-12 | Dow Agrosciences Llc | In vitro methods for the induction and maintenance of plant cell lines as single suspension cells with intact cell walls, and transformation thereof |
-
2009
- 2009-11-19 WO PCT/JP2009/069648 patent/WO2010061781A1/ja active Application Filing
- 2009-11-19 CA CA2744289A patent/CA2744289A1/en not_active Abandoned
- 2009-11-19 RU RU2011126165/10A patent/RU2573906C2/ru not_active IP Right Cessation
- 2009-11-19 AU AU2009320881A patent/AU2009320881B2/en not_active Ceased
- 2009-11-19 UA UAA201107956A patent/UA110691C2/uk unknown
- 2009-11-19 CA CA2977823A patent/CA2977823A1/en not_active Abandoned
- 2009-11-19 JP JP2010540461A patent/JP5800505B2/ja not_active Expired - Fee Related
- 2009-11-19 CA CA2977820A patent/CA2977820A1/en not_active Abandoned
- 2009-11-19 MX MX2011005480A patent/MX336067B/es unknown
- 2009-11-19 KR KR1020117014559A patent/KR101682731B1/ko active IP Right Grant
- 2009-11-19 EP EP09829029A patent/EP2365061A4/en not_active Withdrawn
- 2009-11-19 US US13/130,099 patent/US9169463B2/en not_active Expired - Fee Related
- 2009-11-19 CN CN200980146977.1A patent/CN102245757B/zh not_active Expired - Fee Related
- 2009-11-19 BR BRPI0921371-6A2A patent/BRPI0921371A2/pt not_active IP Right Cessation
- 2009-11-24 TW TW098139923A patent/TWI539000B/zh not_active IP Right Cessation
- 2009-11-25 AR ARP090104560A patent/AR074406A1/es unknown
-
2011
- 2011-05-03 IL IL212638A patent/IL212638A/en not_active IP Right Cessation
- 2011-05-05 ZA ZA2011/03268A patent/ZA201103268B/en unknown
- 2011-06-15 CO CO11074347A patent/CO6341484A2/es unknown
-
2015
- 2015-09-24 US US14/864,712 patent/US20160008434A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BRPI0921371A2 (pt) | 2014-11-18 |
CN102245757B (zh) | 2014-11-26 |
US9169463B2 (en) | 2015-10-27 |
KR101682731B1 (ko) | 2016-12-05 |
CA2977820A1 (en) | 2010-06-03 |
IL212638A (en) | 2017-08-31 |
UA110691C2 (uk) | 2016-02-10 |
AR074406A1 (es) | 2011-01-12 |
TW201024415A (en) | 2010-07-01 |
TWI539000B (zh) | 2016-06-21 |
CN102245757A (zh) | 2011-11-16 |
JP5800505B2 (ja) | 2015-10-28 |
EP2365061A1 (en) | 2011-09-14 |
IL212638A0 (en) | 2011-07-31 |
US20160008434A1 (en) | 2016-01-14 |
AU2009320881B2 (en) | 2015-01-22 |
EP2365061A4 (en) | 2013-03-13 |
US20110223143A1 (en) | 2011-09-15 |
MX2011005480A (es) | 2011-06-20 |
RU2573906C2 (ru) | 2016-01-27 |
WO2010061781A1 (ja) | 2010-06-03 |
RU2011126165A (ru) | 2013-01-10 |
CA2977823A1 (en) | 2010-06-03 |
ZA201103268B (en) | 2012-07-25 |
CO6341484A2 (es) | 2011-11-21 |
KR20110094084A (ko) | 2011-08-19 |
AU2009320881A1 (en) | 2010-06-03 |
CA2744289A1 (en) | 2010-06-03 |
JPWO2010061781A1 (ja) | 2012-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0516969A (pt) | método de preparar uma composição terapêutica, composição terapêutica, e, método de tratar um paciente humano sofrendo de hematopoiese deficiente | |
ES2572214T3 (es) | Métodos para expansión celular y usos de células y medios acondicionados producidos de este modo para terapia | |
MX353245B (es) | Metodos para reprogramar células y sus usos. | |
NZ609731A (en) | Compositions of adult organ stem cells and uses thereof | |
WO2008137641A3 (en) | Ex vivo expansion of human hematopoietic stem cells | |
PL1970068T3 (pl) | Naprawa tkanek z wykorzystaniem komórek multipotencjalnych | |
WO2008056368A3 (en) | Use of ex-vivo cultured hematopoietic cells for treatment of peripheral vascular diseases | |
NZ593364A (en) | Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture | |
GB2434157A (en) | Platelets from stem cells | |
BRPI0919804A8 (pt) | Métodos e composição para o tratamento de problemas dermatológicos e/ou condições de cabelo | |
WO2011082038A3 (en) | Improved reprogramming compositions | |
WO2010124142A3 (en) | Cell compositions derived from dedifferentiated reprogrammed cells | |
WO2013070881A8 (en) | Method for elimination of space through tissue approximation | |
BRPI0718114A2 (pt) | método para estimular a produção de fator de crescimento por células de sangue de cordão umbilical humano, método in vitro para expandir células de sangue de cordão umbilical humano, e, método para melhorar sobrevivência e crescimento de células de sangue de cordão umbilical humano transplantadas em um indivíduo | |
MX336067B (es) | Celula madre para uso terapeutico, la cual se deriva de monocito humano y metodo para inducir la misma. | |
MY170013A (en) | Methods and compositions for enhancing stem cell mobilization | |
MX2009004776A (es) | Celulas madre mesenquimaticas derivadas de medula osea como una fuente de progenitores neurales. | |
WO2010062911A3 (en) | Compositions and methods of functionally enhanced in vitro cell culture system | |
MX2016005824A (es) | Metodo de cultivo celular. | |
WO2011054929A3 (fr) | Procede de production de triptolide | |
BR112012022238A2 (pt) | pele artificial | |
AR046123A1 (es) | Aislamiento de celulas simil-celulas madre, uso de las mismas | |
WO2007136760A3 (en) | Method of growth of mesenchymal cells under non-adherent conditions for clinical applications | |
WO2009141163A3 (de) | Bioreaktor und verfahren zum kultivieren von zellen und geweben | |
WO2011043629A3 (ko) | 인간 지방 줄기세포의 고활성을 유도하는 방법 및 배지 |